Navigation Links
GBC Seeks Nominations for Region's Third Annual Bioscience Awards
Date:1/14/2008

BALTIMORE, Jan. 14 /PRNewswire-USNewswire/ -- The Greater Baltimore Committee is seeking nominations for the Third Annual Greater Baltimore Region Bioscience Awards to be held on Tuesday, March 18, 2008. Those interested in nominating a company or individual for an award, visit http://www.gbc.org.

The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience, and President's Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. Self-nominations are accepted and encouraged. Nominations will close on March 10, 2008.

"We want to make sure that the researcher with a marketable idea, the mid-sized medical device company and all in the region's bioscience industry know that we appreciate the contribution they are making to our economy," said Donald C. Fry, President and CEO of the Greater Baltimore Committee.

Judges for the awards are: Ravinder Dhallan, M.D./Ph.D., M.B.A., chairman and chief executive officer, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Aaron H. Heifetz, Ph.D., vice president business development, Cognate BioServices, Inc.; James Hughes, vice president research and development, University of Maryland, Baltimore; Shira Kramer, Ph.D., president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

For more information, contact Lisbeth Pettengill at the Greater Baltimore Committee, 410-727-2820 or email to lisbethp@gbc.org.


'/>"/>
SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
2. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
3. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
4. Genoptix Reports Strong Financial Results For Third Quarter 2007
5. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
6. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
7. Carrington Reports Third Quarter 2007 Results
8. Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results
9. China Kangtai Cactus Biotech, Inc. Reports Third Quarter 2007 Financial Results
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine ... its canine osteoarthritis stem cell product, currently under development for FDA approval. The ... be marketed in the US by Aratana. This product, termed AT-016, is an ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, ... it has received the second $1.0M tranche under ... Research (SBIR) grant valued at up to $3.0 ... aerosolized KL4 surfactant as a potential medical countermeasure ...  Discovery Labs was awarded an initial $1.0 million ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... , , , SAN DIEGO, ... Company will present at the following investor conferences: , , , ... p.m. Eastern Time (ET) on September 9. , Thomas Weisel ... The 2009 Morgan Stanley Global Healthcare Unplugged Conference in New ...
... , , SUNNYVALE, Calif., Sept. ... biopharmaceutical company focused on developing and commercializing innovative small molecule ... today announced that Dr. Glenn Rice, President and COO, will ... , -- Thomas Weisel Partners 2009 Healthcare Conference ...
... , , EMERYVILLE, Calif., ... announced today that new research data will be delivered as ... Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA on ... multi-institutional collaborative in vitro study of Adamas, triple ...
Cached Biology Technology:Gen-Probe to Webcast Four Upcoming Investor Presentations 2Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences 2Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting 2
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Developmental Biology and the University of North Carolina at ... by a small number of genes, can be a ... thaliana, sometimes called thale cress, the researchers identified a ... female, produced plants that survived only long enough to ...
... two species oscillate together (for example, predators and prey), its ... famous example is the Canadian lynx and snowshoe hare, documented ... is the opposite also true" If the preys population doesnt ... not tightly linked in the food web" Among ecologists, this ...
... domesticated pigs in Europe, which many archaeologists believed to ... from the Middle East by Stone Age farmers, new ... led by archaeologists at Durham University, which is published ... Academies of Sciences USA, analysed mitochondrial DNA from ancient ...
Cached Biology News:Auto immune response creates barrier to fertility; could be a step in speciation 2Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology 2Pig study sheds new light on the colonisation of Europe by early farmers 2
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
... S.c. EasyComp Transformation Kit is designed ... cerevisiae cells. Advantages over commonly used ... or LiCl methods include:- Cells can be ... minutes - Competent cell preparation and transformation ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Biology Products: